Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04648228 · ClinicalTrials.gov registry record · NA

Pain and Opioids: Integrated Treatment In Veterans

A NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of New Mexi.

Active
Registry status
NA
Development phase
157
Enrollment target
4
Study locations

NCT04648228: Active NA study of Chronic Pain and Opioid Use Disorder, sponsored by University of New Mexi.

NCT04648228 is a NA study of Chronic Pain and Opioid Use Disorder that is active but no longer recruiting, run by University of New Mexi. The registered enrollment target is 157 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04648228, a NA study of Chronic Pain and Opioid Use Disorder, is active but no longer recruiting, sponsored by University of New Mexi.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
157 participants
Enrollment target
4
Study locations

Study Summary

This trial will recruit veterans with chronic pain (N = 160) who are prescribed buprenorphine for the treatment of opioid use disorder (OUD). We seek to: (1) examine the efficacy of an integrated treatment to reduce pain interference (Acceptance and Commitment Therapy and Mindfulness-Based Relapse Prevention \[ACT + MBRP\]) compared to an education control (EC) consisting of a protocol-based series of education sessions concerning chronic pain, opioids, and buprenorphine use and (2) examine how theoretically-relevant treatment mechanisms of pain acceptance, engagement in values-based action, and opioid craving are related to treatment outcomes. Interventions will be delivered via the VA Video Connect telehealth modality.

Primary Outcome

Patient Reported Outcome Measurement Information System (PROMIS) Bank v1.0 Pain Interference- The National Institutes of Health (NIH) PROMIS toolkit measure for pain interference will be assessed via 8 items.

Interventions

  • BEHAVIORAL ACT+MBRP
  • BEHAVIORAL Education control

Study Locations (4)

New Mexico

  • New Mexico VA Healthcare System - Albuquerque
  • University of New Mexico - Albuquerque

California

  • San Francisco VA Health Care System - San Francisco

Washington

  • Puget Sound VA Healthcare System - Tacoma

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2021-07-01
Est. Completion 2026-08-31
Phase NA
University of New Mexi

76 total trials

What the registry record for NCT04648228 still lists

NCT04648228 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (80% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which ACT+MBRP is the first listed.

NCT04648228 reports a single indexed study location in New Mexico, California, Washington.

Frequently Asked Questions

What is clinical trial NCT04648228 about?

NCT04648228 is a clinical study titled "Pain and Opioids: Integrated Treatment In Veterans". This trial will recruit veterans with chronic pain (N = 160) who are prescribed buprenorphine for the treatment of opioid use disorder (OUD). We seek to: (1) examine the efficacy of an integrated treatment to reduce pain interference (Acceptance and Commitment Therapy and Mindfulness-Based Relapse P...

What is the current status of trial NCT04648228?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 157 participants. The study started on 2021-07-01. Estimated completion is 2026-08-31.

What conditions does trial NCT04648228 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Opioids; Harmful Use.

What interventions are being tested in trial NCT04648228?

The interventions under investigation include: ACT+MBRP (BEHAVIORAL), Education control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04648228?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04648228 being conducted?

This trial has 4 study locations across California, New Mexico, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04648228's enrollment target sits among peer trials

157 102nd of 301 higher than 200 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05052541 · 157 participants · Phase 3

    Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

  • NCT05076942 · 157 participants · Phase 2

    Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

  • NCT06396598 · 157 participants · NA

    Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

  • NCT06655246 · 157 participants · Phase 1

    A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04648228, the US trial registry maintained by the National Library of Medicine. NCT04648228 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.